SC
LLY icon

Sculptor Capital’s Eli Lilly LLY Stock Holding History

Sculptor Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-19,222
Closed -$6.23M – 1116
2022
Q2 		$6.23M Sell
19,222
-125,121
-87% -$37.6M 0.07% 343
2022
Q1 		$41.3M Buy
144,343
+54,722
+61% +$14.1M 0.32% 49
2021
Q4 		$24.8M Buy
+89,621
New +$22.7M 0.21% 72
2015
Q1 		– Sell
-41,233
Closed -$2.85M – 616
2014
Q4 		$2.85M Sell
41,233
-26,200
-39% -$1.77M 0.01% 531
2014
Q3 		$4.37M Sell
67,433
-16,000
-19% -$1.01M 0.01% 529
2014
Q2 		$5.19M Sell
83,433
-34,600
-29% -$2.06M 0.02% 514
2014
Q1 		$6.95M Sell
118,033
-223,537
-65% -$12.5M 0.02% 446
2013
Q4 		$17.4M Buy
341,570
+107,470
+46% +$5.38M 0.04% 364
2013
Q3 		$11.8M Buy
234,100
+61,734
+36% +$3.23M 0.03% 429
2013
Q2 		$8.47M Buy
+172,366
New +$9.38M 0.03% 444

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sculptor Capital's LLY Position: Q3 2022 in Review

Sculptor Capital sold out of Eli Lilly (LLY) in Q3 2022, closing a stake of 19,222 shares — an estimated $6.23M sold.

Sculptor Capital first reported a position in LLY in Q2 2013 and held it in 10 quarters. The position peaked at $41.3M in Q1 2022. 2,484 funds tracked by Wall St. Rank hold LLY as of Q3 2022.

  • Sculptor Capital reported no remaining Eli Lilly position as of Q3 2022 after selling out during the quarter.
  • Sculptor Capital sold 19,222 Eli Lilly shares in Q3 2022, an estimated $6.23M.
  • Sculptor Capital first reported a position in Eli Lilly in Q2 2013 and held it in 10 quarters.
  • Sculptor Capital's Eli Lilly position peaked at $41.3M in Q1 2022.
  • 2,484 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2022.

Based on Sculptor Capital's 13F filing for Q3 2022, filed 14 Nov 2022.